Mims

MIMS commonly refers to the Monthly Index of Medical Specialties, a medical reference resource used by healthcare professionals to obtain concise, evidence-based information about medicines. It provides details on brand and generic names, indications, dosing guidelines, contraindications, adverse effects, drug interactions, pharmacology notes, and regulatory status. Published monthly in various regional editions and available in print and online formats, MIMS is designed to support safe prescribing and pharmaceutical care in hospitals, clinics, and community practice.

The content is typically sourced from regulatory authorities, drug manufacturers, and clinical literature, and is updated to reflect new approvals, safety advisories, and changes in labeling. Editions may differ by country to reflect local formularies, product availability, and regulatory requirements. Beyond monographs, MIMS often includes summary clinical information, formulary recommendations, and quick reference indexes to assist clinicians in day-to-day decision making. Access is usually via subscription, with publishers offering regional versions tailored to specific healthcare markets.

While widely used as a practical prescribing resource, MIMS is intended to complement, not replace, local formularies, clinical guidelines, and individual patient considerations. Users are advised to verify information against current regulatory statuses and country-specific product details, as formulations and approvals can vary geographically and may change between editions.

The acronym MIMS can also be used in other contexts outside medicine to denote different organizations or systems, depending on usage. However, the medical Monthly Index of Medical Specialties remains the dominant and most widely recognized meaning in international healthcare settings.